Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Reducing radiation treatment dose could improve the quality of life (QOL) of patients with good-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma (OPSCC). Whether reduced-dose radiation produces disease control and QOL equivalent to standard chemoradiation is not proven. In...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2021-03, Vol.39 (9), p.956-965
Hauptverfasser:	Yom, Sue S, Torres-Saavedra, Pedro, Caudell, Jimmy J, Waldron, John N, Gillison, Maura L, Xia, Ping, Truong, Minh T, Kong, Christina, Jordan, Richard, Subramaniam, Rathan M, Yao, Min, Chung, Christine H, Geiger, Jessica L, Chan, Jason W, O'Sullivan, Brian, Blakaj, Dukagjin M, Mell, Loren K, Thorstad, Wade L, Jones, Christopher U, Banerjee, Robyn N, Lominska, Christopher, Le, Quynh-Thu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Chemoradiotherapy - mortality Female Follow-Up Studies Humans Male Middle Aged ORIGINAL REPORTS Oropharyngeal Neoplasms - pathology Oropharyngeal Neoplasms - radiotherapy Oropharyngeal Neoplasms - therapy Oropharyngeal Neoplasms - virology Papillomaviridae - isolation & purification Papillomavirus Infections - complications Papillomavirus Infections - virology Prognosis Radiotherapy Dosage Radiotherapy, Intensity-Modulated - mortality Squamous Cell Carcinoma of Head and Neck - pathology Squamous Cell Carcinoma of Head and Neck - radiotherapy Squamous Cell Carcinoma of Head and Neck - therapy Squamous Cell Carcinoma of Head and Neck - virology Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!